{
  "id": 843393,
  "title": "10x Genomics director John Stuelpnagel sells $1.15m in shares",
  "url": "https://urgent.news/2026/08/14/10x-genomics-director-john-stuelpnagel-sells-1-15m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-14T06:15:57.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/10x-genomics-director-john-stuelpnagel-sells-115m-in-shares-93CH-4859794"
  },
  "original_language": "en",
  "account": "John R. Stuelpnagel, a director at 10x Genomics, sold 20,000 shares of the company's Class A Common Stock, amounting to $1,155,055, on August 11, 2026. The shares were sold at prices between $57.5812 and $58.725 per share. One transaction involved the sale of 17,000 shares at a weighted average price of $57.5812. Additionally, 3,000 shares were sold at $58.725. This sale occurred as TXG stock approaches its 52-week high of $60.69, following a significant 339% increase over the past year. Currently, the stock has a market capitalization of $7.58 billion. Post-transactions, Stuelpnagel retains 348,436 shares of 10x Genomics Class A Common Stock. According to InvestingPro analysis, the stock is currently overvalued compared to its Fair Value. Investors can access further insights through 15 ProTips and in-depth financial metrics. In related news, 10x Genomics reported stronger-than-expected second-quarter 2026 results, with revenue of $151.04 million and an adjusted loss per share of $0.14. Despite this, the stock declined as investors weighed the company's more cautious outlook and its shift to the Atera platform. Canaccord raised its price target for 10x Genomics to $60, signaling a 15% potential upside.",
  "summary": null,
  "key_points": [
    "10x Genomics director John Stuelpnagel sold $1.15m in shares",
    "Sale occurred on August 11, 2026, at $57.58-$58.73 per share",
    "Stuelpnagel retains 348,436 shares after transaction"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}